Australia’s Pharmaceutical Benefits Scheme is under attack at the 17th round of Trans Pacific Partnership (TPP) negotiations underway in Lima. It is not just the cheap drugs enjoyed by Australia thanks to this brilliant scheme, it is the very question of national sovereignty.
The Australian delegation is winning accolades around the world for its stand on national sovereignty but this has not yet made headlines locally.
This article discusses the reasons why these negotiations are so critical to our future and concludes with a plea to bring all the pressure we can to bear on politicians of all stripes to maintain our proud bipartisan stance on this issue.